Skip to main content
Top
Published in: Infection 5/2018

01-10-2018 | Review

Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature

Authors: Francesca Giovannenze, Vito Stifano, Giancarlo Scoppettuolo, Fernando Damiano, Federico Pallavicini, Giovanni Delogu, Ivana Palucci, Alessandro Rapisarda, Cosimo Sturdà, Angelo Pompucci

Published in: Infection | Issue 5/2018

Login to get access

Abstract

Purpose

Mycobacterium abscessus, and rapidly growing mycobacteria in general, are rare but increasing causes of central nervous system (CNS) infections. The aim of this study is to highlight the importance of considering these microorganism in the differential diagnosis of CNS infections, obtaining a prompt diagnosis, and improving clinical outcomes.

Methods

Case report and literature review.

Results

We report a case of meningeal infection in a patient who underwent decompressive craniectomy after a craniofacial trauma. The diagnosis was made analyzing a sample obtained during a second operation of cranioplasty. A regimen of amikacin, clarithromycin, and imipenem/cilastatin was started. In the following days, the patient experienced a variety of side effects. So, first clarithromycin was replaced with linezolid, then amikacin was stopped and cefoxitin added to the therapy and at the end all the antibiotics were withdrawn. The patient was discharged in good conditions and a clinical interdisciplinary follow-up was started. After 12 months, the patient is still doing well. After a literature analysis, 15 cases of M. abscessus CNS infections were identified. Various modes of acquisition, underlying disease and therapeutic schemes were evident.

Conclusions

Considering the results of the literature analysis and the increasing incidence of M. abscessus, all specialists involved in the management of CNS infection should be aware of the importance of atypical microorganisms in differential diagnosis.
Literature
1.
go back to reference Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N, Cambau E. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Rev Anti Infect Ther 2016;14:1139–54CrossRef Mougari F, Guglielmetti L, Raskine L, Sermet-Gaudelus I, Veziris N, Cambau E. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Rev Anti Infect Ther 2016;14:1139–54CrossRef
3.
go back to reference Odell ID, Cloud JL, Seipp M, Wittwer CT. Rapid species identification within the Mycobacterium chelonae–abscessus group by high-resolution melting analysis of hsp65 pcr products. Am J Clin Pathol. 2005;123:96–101.CrossRef Odell ID, Cloud JL, Seipp M, Wittwer CT. Rapid species identification within the Mycobacterium chelonaeabscessus group by high-resolution melting analysis of hsp65 pcr products. Am J Clin Pathol. 2005;123:96–101.CrossRef
4.
go back to reference Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175–8.PubMedPubMedCentral Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31:175–8.PubMedPubMedCentral
5.
go back to reference Sali M, De Maio F, Caccuri F, Campilongo F, Sanguinetti M, Fiorentini S, Delogu G, Giagulli C. Multicenter evaluation of anyplex plus mtb/ntm mdr-tb assay for rapid detection of Mycobacterium tuberculosis complex and multidrug-resistant isolates in pulmonary and extrapulmonary specimens. J Clin Microbiol. 2016;54:59–63.CrossRef Sali M, De Maio F, Caccuri F, Campilongo F, Sanguinetti M, Fiorentini S, Delogu G, Giagulli C. Multicenter evaluation of anyplex plus mtb/ntm mdr-tb assay for rapid detection of Mycobacterium tuberculosis complex and multidrug-resistant isolates in pulmonary and extrapulmonary specimens. J Clin Microbiol. 2016;54:59–63.CrossRef
6.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, Subcommittee ATSMD. American Thoracic S and Infectious Disease Society of A. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.CrossRef Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, Subcommittee ATSMD. American Thoracic S and Infectious Disease Society of A. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.CrossRef
7.
go back to reference Chan KH, Mann KS, Seto WH. Infection of a shunt by mycobacterium fortuitum: case report. Neurosurgery. 1991;29:472–4.CrossRef Chan KH, Mann KS, Seto WH. Infection of a shunt by mycobacterium fortuitum: case report. Neurosurgery. 1991;29:472–4.CrossRef
8.
go back to reference Madaras-Kelly KJ, DeMasters TA, Stevens DL. Mycobacterium fortuitum meningitis associated with an epidural catheter: case report and a review of the literature. Pharmacotherapy. 1999;19:661–6.CrossRef Madaras-Kelly KJ, DeMasters TA, Stevens DL. Mycobacterium fortuitum meningitis associated with an epidural catheter: case report and a review of the literature. Pharmacotherapy. 1999;19:661–6.CrossRef
9.
go back to reference Midani S, Rathore MH. Mycobacterium fortuitum infection of ventriculoperitoneal shunt. South Med J. 1999;92:705–7.CrossRef Midani S, Rathore MH. Mycobacterium fortuitum infection of ventriculoperitoneal shunt. South Med J. 1999;92:705–7.CrossRef
10.
go back to reference Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis. 2008;8:390–8.CrossRef Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis. 2008;8:390–8.CrossRef
11.
go back to reference Viswanathan R, Bhagwati SN, Iyer V, Newalkar P. Ventriculo-peritoneal shunt infection by Mycobacterium fortuitum in an adult. Neurol India. 2004;52:393–4.PubMed Viswanathan R, Bhagwati SN, Iyer V, Newalkar P. Ventriculo-peritoneal shunt infection by Mycobacterium fortuitum in an adult. Neurol India. 2004;52:393–4.PubMed
12.
go back to reference Martin JS, Zagzag D, Egan M, Milla S, Harter D, Lighter-Fisher J. Intracranial Mycobacterium abscessus infection in a healthy toddler. Pediatr Infect Dis J. 2015;34:223–4.CrossRef Martin JS, Zagzag D, Egan M, Milla S, Harter D, Lighter-Fisher J. Intracranial Mycobacterium abscessus infection in a healthy toddler. Pediatr Infect Dis J. 2015;34:223–4.CrossRef
13.
go back to reference Maniu CV, Hellinger WC, Chu SY, Palmer R, Alvarez-Elcoro S. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Clin Infect Dis. 2001;33:745–8.CrossRef Maniu CV, Hellinger WC, Chu SY, Palmer R, Alvarez-Elcoro S. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Clin Infect Dis. 2001;33:745–8.CrossRef
14.
go back to reference Liebeskind DS, Ostrzega N, Wasterlain CG, Buttner EA. Neurologic manifestations of disseminated infection with Mycobacterium abscessus. Neurology. 2001;56:810–3.CrossRef Liebeskind DS, Ostrzega N, Wasterlain CG, Buttner EA. Neurologic manifestations of disseminated infection with Mycobacterium abscessus. Neurology. 2001;56:810–3.CrossRef
15.
go back to reference Lee MR, Cheng A, Lee YC, Yang CY, Lai CC, Huang YT, Ho CC, Wang HC, Yu CJ, Hsueh PR. Cns infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother. 2012;67:222–5.CrossRef Lee MR, Cheng A, Lee YC, Yang CY, Lai CC, Huang YT, Ho CC, Wang HC, Yu CJ, Hsueh PR. Cns infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. J Antimicrob Chemother. 2012;67:222–5.CrossRef
16.
go back to reference Levy ZD, Du V, Chiluwal A, Chalif DJ, Ledoux DE. Ventriculoperitoneal shunt infection with mycobacterium abscessus: a rare cause of ventriculitis. World Neurosurg. 2016;86:510 e1–4.CrossRef Levy ZD, Du V, Chiluwal A, Chalif DJ, Ledoux DE. Ventriculoperitoneal shunt infection with mycobacterium abscessus: a rare cause of ventriculitis. World Neurosurg. 2016;86:510 e1–4.CrossRef
17.
go back to reference Baidya A, Tripathi M, Pandey P, Singh UB. Mycobacterium abscessus as a cause of chronic meningitis: a rare clinical entity. Am J Med Sci. 2016;351:437–9.CrossRef Baidya A, Tripathi M, Pandey P, Singh UB. Mycobacterium abscessus as a cause of chronic meningitis: a rare clinical entity. Am J Med Sci. 2016;351:437–9.CrossRef
18.
go back to reference Montero JA, Alrabaa SF, Wills TS. Mycobacterium abscessus ventriculoperitoneal shunt infection and review of the literature. Infection. 2016;44:251–3.CrossRef Montero JA, Alrabaa SF, Wills TS. Mycobacterium abscessus ventriculoperitoneal shunt infection and review of the literature. Infection. 2016;44:251–3.CrossRef
Metadata
Title
Incidental intraoperative diagnosis of Mycobacterium abscessus meningeal infection: a case report and review of the literature
Authors
Francesca Giovannenze
Vito Stifano
Giancarlo Scoppettuolo
Fernando Damiano
Federico Pallavicini
Giovanni Delogu
Ivana Palucci
Alessandro Rapisarda
Cosimo Sturdà
Angelo Pompucci
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1141-5

Other articles of this Issue 5/2018

Infection 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine